Updating Clinical Practice in Rheumatoid Arthritis: New Approaches for Optimal Care
The goal of this expert roundtable discussion is to expand the ability of rheumatology clinicians to implement best practices in the management of RA based on the latest clinical evidence.
Medium: Video Roundtable
Commercial Support Statetements: Supported by an independent educational grant from AbbVie, Inc and Lilly.
Joint Providers: MCM Education, Postgraduate Institute for Medicine
Target Audience
This activity is intended for rheumatology clinicians including physicians, PAs, NPs, and RNs.
Learning Objectives
Upon completion of this educational activity, the participant should be able to:
- Utilize current guideline-based treatment options for patients with early RA;
- Define appropriate RA treatment targets based on individual characteristics and disease presentation;
- Incorporate the appropriate use of validated composite measures of disease activity for patients with RA;
- Discuss the characteristics of DMARDs that may be appropriate for patients with established RA, including their efficacy, safety, and use in combination regimens;
- Outline the disease and patient factors that would influence DMARD selection;
- Implement approaches for increasing patient collaboration and shared decision making when developing individualized treatment plans;
- Discuss emerging investigational therapies for RA in late stages of clinical development;
- Provide appropriate care and counsel for patients and their families.
Chair
Tuhina Neogi, MD, PhD
Associate Professor of Medicine and Epidemiology
Boston University School of Medicine
Boston, MA
Naomi Amudala, MSN, RN, FNP-BC
Clinical Instructor and Nurse Practitioner
Vasculitis Center/Rheumatology
Boston University School of Medicine
Boston, MA
Nancy Figueiredo, RN
Rheumatology Nurse
Boston Medical Center
Boston, MA
Patient Advocate
Saralynn Allaire, ScD
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The University of Chicago Pritzker School of Medicine, Postgraduate Institute for Medicine (PIM) and MCM Education. The University of Chicago Pritzker School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement
The University of Chicago Pritzker School of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.